Search Results - "Serrano‐Del Valle, Alfonso"
-
1
Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐XL in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients
Published in Molecular oncology (01-12-2023)“…A better understanding of multiple myeloma (MM) biology has led to the development of novel therapies. However, MM is still an incurable disease and new…”
Get full text
Journal Article -
2
Neutrophil stunning by metoprolol reduces infarct size
Published in Nature communications (18-04-2017)“…The β1-adrenergic-receptor (ADRB1) antagonist metoprolol reduces infarct size in acute myocardial infarction (AMI) patients. The prevailing view has been that…”
Get full text
Journal Article -
3
Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
Published in Frontiers in cell and developmental biology (16-04-2019)“…Over the past decades, immunotherapy has demonstrated a prominent clinical efficacy in a wide variety of human tumors. For many years, apoptosis has been…”
Get full text
Journal Article -
4
Behavioural immune landscapes of inflammation
Published in Nature (London) (20-01-2022)“…Transcriptional and proteomic profiling of individual cells have revolutionized interpretation of biological phenomena by providing cellular landscapes of…”
Get full text
Journal Article -
5
Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-X L in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patients
Published in Molecular oncology (01-12-2023)“…A better understanding of multiple myeloma (MM) biology has led to the development of novel therapies. However, MM is still an incurable disease and new…”
Get full text
Journal Article -
6
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis
Published in Oncoimmunology (31-12-2022)“…Immunogenic cell death (ICD) has been proposed to be a crucial process for antitumor immunosurveillance. ICD is characterized by the exposure and emission of…”
Get full text
Journal Article -
7
Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
Published in Frontiers in cell and developmental biology (27-11-2019)Get full text
Journal Article -
8
Future prospects for mitosis-targeted antitumor therapies
Published in Biochemical pharmacology (01-08-2021)“…[Display omitted] Dysregulation of cell cycle progression is a hallmark of cancer cells. In recent years, efforts have been devoted to the development of new…”
Get full text
Journal Article -
9
Cytofluorometric assessment of calreticulin exposure on CD38 + plasma cells from the human bone marrow
Published in Methods in cell biology (2024)“…Exposure of the endoplasmic reticulum chaperone calreticulin (CALR) on the surface of stressed and dying cells is paramount for their effective engulfment by…”
Get full text
Journal Article -
10
Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties
Published in Journal of medicinal chemistry (13-08-2015)“…New organometallic gold(III) and platinum(II) complexes containing iminophosphorane ligands are described. Most of them are more cytotoxic to a number of…”
Get full text
Journal Article -
11
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis
Published in OncoImmunology (31-12-2022)“…Immunogenic cell death (ICD) has been proposed to be a crucial process for antitumor immunosurveillance. ICD is characterized by the exposure and emission of…”
Get full text
Report